Justin Holko

Justin Holko is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as Senior Vice President and Head of the Global Oncology/Hematology Commercial Business Unit at Regeneron since June 2019. Prior to this role, Justin held various leadership positions at Merck from August 2000 to May 2019, including U.S. Marketing Leader for KEYTRUDA in multiple cancer indications, Executive Director of Investor Relations, and Director of Global Market Access. Justin's educational background includes a Bachelor of Engineering in Chemical Engineering and Chemistry from Vanderbilt University and an MBA in Global Business and Strategy from Rutgers University - Newark.